期刊文献+

应注意区分多发性硬化与视神经脊髓炎发病机制与治疗的异同 被引量:1

原文传递
导出
摘要 中枢神经系统(central nervous system,CNS)炎性脱髓鞘病指一类免疫介导的髓鞘脱失为主的疾病.最常见的是多发性硬化(multiple sclerosis,MS)与视神经脊髓炎(neuromyelitis optica,NMO).近年来认为亚洲人群NMO的发病更多于MS,两者在发病机制、病理损伤及临床治疗上都有所不同,因此,掌握两者的发病机制及临床治疗的异同点及研究进展,对指导临床实际工作将有重要意义。
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第39期3041-3043,共3页 National Medical Journal of China
基金 海军总医院归国人员创新技术项目(GGCX201205)
  • 相关文献

参考文献16

二级参考文献134

  • 1戚晓昆.视神经脊髓炎的诊断与治疗[J].中国全科医学,2007,10(12):955-956. 被引量:8
  • 2Jacob A,Matiello M,Wingerchuk DM,et al.Neuromyelitis optica:changing concepts.J Neuroimmunol,2007,187:126-138.
  • 3Wingerchuk DM,Lennon VA,Pittock SJ,et al.Revised diagnostic criteria for neuromyelitis optica.Neurology,2006,66:1485-1489.
  • 4Wingerchuk DM,Hogancamp WF,O'Brien PC,et al.The clinical course of neuromyelitis optica (Devic's syndrome).Neurology,1999,53:1107-1114.
  • 5Abou Zeid N,Bhatti MT.Acute inflammatory demyelinating optic neuritis:evidence-based visual and neurological considerations.Neurologist,2008,14:207-223.
  • 6Pelidou SH,Giannopoulos S,Tzavidi S,et al.Multiple sclerosis presented as clinically isolated syndrome:the need for early diagnosis and treatment.Ther Clin Risk Manag,2008,4:627-630.
  • 7McDonald WI,Compston A,Edan G,et al.Recommended diagnostic criteria for multiple sclerosis:guidelines from the International Panel on the diagnosis of multiple sclerosis.Ann Neurol,2001,50:121-127.
  • 8Bichuetti DB,Oliveira EM,Souza NA,et al.Neuromyelitis optica in Brazil:a study on clinical and prognostic factors.Mult Scler,2009,15:613-619.
  • 9Miller DH,Weinshenker BG,Filippi M,et al.Differential diagnosis of suspected multiple sclerosis:a consensus approach.Mult Scler,2008,14:1157-1174.
  • 10Nakamura M,Miyazawa I,Fujihara K,et al.Preferential spinal central gray matter involvement in neuromyelitis optica.An MRI study.J Neurol,2008,255:163-170.

共引文献50

同被引文献56

  • 1Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology, 2006, 66:1485-1489.
  • 2Sato DK, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nisbiyama S, Suzuki C, Takai Y, Fujihara K, Itoyama Y, Aoki M. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology, 2013, 80:2210-2216.
  • 3Iaeovetta C, Rudloff E, Kirby R. The role of aquaporin 4 in the brain. Vet Clin Pathol, 2012, 41:32-44.
  • 4Nicchia GP, Rossi A, Mola MG, Pisani F, Stigliano C, Basco D, Mastrototaro M, Svelto M, Frigeri A. Higher order structure of aquaporin-4. Neuroscience, 2010, 165:903-914.
  • 5Saini H, Fernandez G, Kerr D, Levy M. Differential expression of aquaporin- 4 isoforms localizes with neuromyelitis optica disease activity. J Neuroimmunol, 2010, 221:68-72.
  • 6Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol, 2013, 23:661-683.
  • 7Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol, 2007, 6:805-815.
  • 8McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ. CNS aquaporin-4 autoimmunity in children. Neurology, 2008, 71:93- 100.
  • 9Pittock SJ. Neuromyelitis optica: a new perspective. Semin Neurol, 2008, 28:95-104.
  • 10Nakamura M, Miyazawa I, Fujihara K, Nakashima I, Misu T, Watanabe S, Takahashi T, hoyama Y. Preferential spinal central gray matter involvement in neuromyelitis optica: an MRI study. J Neurol, 2008, 255:163-170.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部